Raltegravir Viatris
Active substance: raltegravir
raltegravir potassium
Centralised EU authorisationActive
Marketing holder: Viatris Limited
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 22 |
|
| US 9 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-5042-705a-9204-5b81685321e5,01a1208c-52ca-7876-848b-7404948f5955,01a1208e-1c9c-741e-aef2-ada6097022bf,01a1208e-56c2-77bc-81a5-2d03b9c71297,01a1208e-b7f5-7e48-b5cd-dbd829ad5ece;count=9 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/005813
- Registration status
- Active
- ATC code
- J05AJ01
Sources
- product · EMA · EMEA/H/C/005813 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/005813 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/005813 · Verified 2026-10-09